pluripotent cells with broad differentiation potential.
Embryonic stem cells are pluripotent and can in principle form any cell type. Their clinical use is tightly regulated and protocol-specific.
The therapeutic value of Embryonic Stem Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.
Educational information. Embryonic Stem Cells protocols for several conditions remain investigational; outcomes vary by patient.
GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.
Free medical review